Talaris Therapeutics Inc

NASDAQ:TALS  
7.31
+0.01 (+0.14%)
Earnings Announcements

Talaris Therapeutics Announces First Quarter Results

Published: 05/12/2022 20:59 GMT
Talaris Therapeutics Inc (TALS) - Talaris Therapeutics Announces First Quarter Financial Results and Corporate Update.
Q1 Loss per Share $0.45.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.46

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.49

More details on our Analysts Page.